3QIO
Crystal Structure of HIV-1 RNase H with engineered E. coli loop and N-hydroxy quinazolinedione inhibitor
3QIO の概要
| エントリーDOI | 10.2210/pdb3qio/pdb |
| 関連するPDBエントリー | 3HYF |
| 分子名称 | Gag-Pol polyprotein,Ribonuclease HI,Gag-Pol polyprotein, MANGANESE (II) ION, SULFATE ION, ... (5 entities in total) |
| 機能のキーワード | rnase h, hiv-1, inhibitor, nuclease, transferase, hydrolase-inhibitor complex, hydrolase/inhibitor |
| 由来する生物種 | Human immunodeficiency virus type 1 group M subtype B (HIV-1) 詳細 |
| 細胞内の位置 | Gag-Pol polyprotein: Host cell membrane; Lipid-anchor . Matrix protein p17: Virion membrane; Lipid- anchor . Capsid protein p24: Virion . Nucleocapsid protein p7: Virion . Reverse transcriptase/ribonuclease H: Virion . Integrase: Virion : P04585 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 17445.71 |
| 構造登録者 | |
| 主引用文献 | Lansdon, E.B.,Liu, Q.,Leavitt, S.A.,Balakrishnan, M.,Perry, J.K.,Lancaster-Moyer, C.,Kutty, N.,Liu, X.,Squires, N.H.,Watkins, W.J.,Kirschberg, T.A. Structural and Binding Analysis of Pyrimidinol Carboxylic Acid and N-Hydroxy Quinazolinedione HIV-1 RNase H Inhibitors. Antimicrob.Agents Chemother., 55:2905-2915, 2011 Cited by PubMed Abstract: HIV-1 RNase H breaks down the intermediate RNA-DNA hybrids during reverse transcription, requiring two divalent metal ions for activity. Pyrimidinol carboxylic acid and N-hydroxy quinazolinedione inhibitors were designed to coordinate the two metal ions in the active site of RNase H. High-resolution (1.4 Å to 2.1 Å) crystal structures were determined with the isolated RNase H domain and reverse transcriptase (RT), which permit accurate assessment of the metal and water environment at the active site. The geometry of the metal coordination suggests that the inhibitors mimic a substrate state prior to phosphodiester catalysis. Surface plasmon resonance studies confirm metal-dependent binding to RNase H and demonstrate that the inhibitors do not bind at the polymerase active site of RT. Additional evaluation of the RNase H site reveals an open protein surface with few additional interactions to optimize active-site inhibitors. PubMed: 21464257DOI: 10.1128/AAC.01594-10 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.4011 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






